The Effect of On-line High-flux Hemofiltration Versus Low-flux Hemodialysis on Mortality in Chronic Kidney Failure: A Small Randomized Controlled Trial

American Journal of Kidney Diseases

Volumn 52, Issue 3, 2008, Pages 507-518

  Santoro, Antonio ^a   Mancini, Elena ^a   Bolzani, Roberto ^b   Boggi, Rolando ^c   Cagnoli, Leonardo ^d   Francioso, Angelo ^e   Fusaroli, Maurizio ^f   Piazza, Valter ^g   Rapanà, Renato ^h   Strippoli, Giovanni F M ^i,j  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Ospedale Civile   (Italy)

^d OSPEDALE DEGLI INFERMI   (Italy)

^e S CROCE E CARLE HOSPITAL   (Italy)

^f SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^g IRCCS   (Italy)

^h S Maria della Scaletta Hospital   (Italy)

ⁱ Mario Negri Sud Consortium ^*  (Italy)

^j Medical Scientific Office   (Sweden)

more..

Author keywords

dialysis adequacy; Hemodialysis; hemofiltration; high flux

Indexed keywords

BETA 2 MICROGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMOFILTRATION; HOSPITALIZATION; HUMAN; HYPOTENSION; INTERMETHOD COMPARISON; ITALY; LENGTH OF STAY; MALE; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PREVALENCE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA 2-MICROGLOBULIN; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; FOLLOW-UP STUDIES; HEMOFILTRATION; HOSPITALIZATION; HUMANS; HYPOTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; SERUM ALBUMIN; SURVIVAL ANALYSIS;

EID: 49749084921     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.05.011     Document Type: Article

References (34)

1. US Renal Data System. USRDS 2002 Annual Data Report: Atlas of end-stage renal disease in the United States, Bethesda, MD, USA, 2002. Am J Kidney Dis 41 suppl 2 (2003) S41-S210
2. Locatelli F., Marcelli M., Conte F., et al. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi e Trapianto. Kidney Int 55 (1999) 286-293
3. Mc Donald S.P., Craig J.C., and Australian and New Zealand Pediatric Nephrology Association. Long-term survival of children with end-stage renal disease. N Engl J Med 350 (2004) 2654-2662
4. Cheung A.K., Rocco M.V., Yan G., et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: Results of the HEMO Study. J Am Soc Nephrol 17 (2006) 546-555
5. Canaud B., Bragg-Gresham J.L., Marshall M.R., et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int 69 (2006) 2087-2093
6. Eknoyan G., Beck G.J., Cheung A.K., et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347 (2002) 2000-2019
7. Kooman P.K., van der Sande F.M., and Leunissen K.M.L. Predilution haemofiltration. Nephrol Dial Transplant 17 (2002) 171-172
8. Nakagawa S. Multifactorial evaluation of hemofiltration therapy in comparison with conventional hemodialysis. Artif Organs 4 (1980) 94-102
9. Wizeman V., Lotz C., Techert F., et al. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study. Nephrol Dial Transplant 15 suppl 1 (2000) S143-S148
10. Henderson L., Besarb A., Michael A., and Bluemle L.W. Blood purification by ultrafiltration and fluid replacement/diafiltration. Trans Am Soc Artif Intern Organs 16 (1967) 216-222
11. Schaefer K., and von Herrach D. Hemofiltration in the past and present. Contrib Nephrol 96 (1992) 64-76
12. Quellhorst E. Cardiovascular problems in end-stage renal failure: Haemofiltration. Contrib Nephrol 78 (1985) 212-230
13. Altieri P., Sorba G.B., Bolasco P.G., et al. On-line predilution hemofiltration versus ultrapure high-flux hemodialysis: A multicenter prospective study in 23 patients. Blood Purif 15 (1997) 169-181
14. Keshaviah P., Collins A., Berkseth R., et al. Adequacy, benefits, complications, dose and efficacy of filtration-The Minneapolis experience. J Blood Purif 2 (1984) 149-157
15. Cheung A.K., Levin N.W., Greene T., et al. Effects of high-flux hemodialysis on clinical outcomes: Results of the HEMO Study. J Am Soc Nephrol 14 (2003) 3251-3263
16. Jirka T., Cesare S., Di Benedetto A., et al. The impact of on-line hemodiafiltration (HDF) on patient survival: Results from a large network database. Nephrol Dial Transplant 20 suppl 4 (2005) S18-S19
17. Santoro A., Mancini E., and Zucchelli P. The impact of hemofiltration on the systemic cardiovascular response. Nephrol Dial Transpl 15 suppl 2 (2000) S49-S54
18. Altieri P., Sorba G., Bolasco P., et al. Comparison between hemofiltration and hemodiafiltration in a long-term prospective cross-over study. J Nephrol 17 (2004) 414-422
19. Koch M., Thomas B., Tschope W., and Ritz E. Survival and predictors of death in dialyzed diabetic patients. Diabetologia 36 (1993) 1113-1117
20. Shoji T., Tsubakihara Y., Fujii M., and Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in haemodialysis patients. Kidney Int 66 (2004) 1212-1220
21. Locatelli F., DiFilippo S., and Manzoni C. Removal of small and middle molecules by convective techniques. Nephrol Dial Transplant 15 suppl 2 (2000) S37-S44
22. Van Kuijk W.H.M., Hillion D., Saviou C., and Leunissen K.M.L. Critical role of extracorporeal blood temperature in the hemodynamic response during hemofiltration. J Am Soc Nephrol 8 (1997) 949-955
23. Bergstrom J., Asaba H., Fuerst P., and Oules R. Dialysis ultrafiltration and blood pressure. Proc EDTA 13 (1976) 293-300
24. Maggiore Q., Pizzarelli F., Sisca S., et al. Blood temperature and vascular stability during hemodialysis and hemofiltration. Trans Am Soc Artif Intern Organs 28 (1982) 523-527
25. Schaefer K., and von Herrath D. Hemofiltration in the past and present. Contrib Nephrol 96 (1992) 64-76
26. Genovesi S., Bracchi O., Fabbrini P., et al. Differences in heart rate variability during hemodialysis and hemofiltration. Nephrol Dial Transplant 22 (2007) 2256-2262
27. National Kidny Foundation. K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy: Update 2000. Am J Kidney Dis 37 suppl 1 (2001) S7-S64
28. Maduell F., Navarro V., Torregrosa E., et al. Change from three times a week on-line hemodiafiltration to short daily on-line hemodiafiltration. Kidney Int 64 (2003) 305-313
29. Bossola M., Tazza L., Giungi S., and Lucani G. Anorexia in hemodialysis patients: An update. Kidney Int 70 (2006) 417-422
30. Schiffl H., D'Agostini B., and Held E. Removal of beta2-microglobulin by hemodialysis and hemofiltration: A four year follow up. Biomater Artif Cells Immobilisation Biotechnol 20 (1992) 1223-1232
31. Quellhorst E., Hildebrand U., and Solf A. Long-term morbidity: Hemofiltration vs hemodialysis. Contrib Nephrol 113 (1995) 110-111
32. Rabindranath K.S., Strippoli G.F.M., Roderick P., Wallace S., MacLeod A., and Daly C. Comparison of hemodialysis, hemofiltration and acetate-free biofiltration for ESRD: Systematic review. Am J Kidney Dis 45 (2005) 437-447
33. Schiffl H. Hemodiafiltration does not increase the risk for mortality in ESRD. Am J Kidney Dis 46 (2005) 167-168
34. Locatelli F. Comparison of hemodialysis, hemodiafiltration, and hemofiltration: Systematic review or systematic error?. Am J Kidney Dis 46 (2005) 787-788